BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9206116)

  • 21. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of exocrine pancreatic secretion by leptin through CCK(1)-receptors and afferent vagal fibres in the rat.
    Guilmeau S; Nagain-Domaine C; Buyse M; Tsocas A; Rozé C; Bado A
    Eur J Pharmacol; 2002 Jun; 447(1):99-107. PubMed ID: 12106809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The exocrine pancreas. II. Regulation of pancreatic secretion].
    Ribet A; Pascal JP; Frexinos J
    Nouv Presse Med; 1972 Nov; 1(40):2699-706. PubMed ID: 4565316
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence against cholecystokinin mediation of basal and bombesin-stimulated pancreatic secretion in the rat.
    Wisner JR; Ozawa S; Renner IG
    Gastroenterology; 1988 Jul; 95(1):151-5. PubMed ID: 3371609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Desbois C; Romé V; Bernard C; Dufresne M; Moroder L; Gully D; Chayvialle JA; Fourmy D; Guilloteau P
    Pflugers Arch; 1999 Jun; 438(1):86-93. PubMed ID: 10370091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
    Kim H; Kim KH
    Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secretion of the pancreas].
    Takeuchi T
    Nihon Rinsho; 1986 Jul; 44(7):1552-7. PubMed ID: 3531615
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent data on the physiology of the exocrine pancreas].
    Bonfils S; Gislon J; Shimazu I
    Pathol Biol (Paris); 1971 Jan; 19(1):77-101. PubMed ID: 4926334
    [No Abstract]   [Full Text] [Related]  

  • 30. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways.
    Sabbatini ME; Rodríguez MR; Dabas P; Vatta MS; Bianciotti LG
    Eur J Pharmacol; 2007 Dec; 577(1-3):192-202. PubMed ID: 17900562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.
    Rivard N; Guan D; Maouyo D; Grondin G; Bérubé FL; Morisset J
    Endocrinology; 1991 Dec; 129(6):2867-74. PubMed ID: 1954873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of secretion on vagal stimulation-evoked exocrine pancreatic secretion in the rat.
    Wisdom D; Singh J; Camello PJ; Pariente JA; Salido GM
    Rev Esp Fisiol; 1993 Mar; 49(1):31-5. PubMed ID: 7690979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin inhibits food intake at a peripheral extragastric site.
    Zittel TT; Elm BV; Teichmann RK; Becker HD; Raybould HE
    Ann N Y Acad Sci; 1994 Mar; 713():431-4. PubMed ID: 8185211
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
    Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
    Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both free and complexed trypsin inhibitors stimulate pancreatic secretion and change duodenal enzyme levels.
    Pusztai A; Grant G; Bardocz S; Baintner K; Gelencsér E; Ewen SW
    Am J Physiol; 1997 Feb; 272(2 Pt 1):G340-50. PubMed ID: 9124359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the influence of CCK receptor blockade on GRP-mediated pancreatic secretion.
    Stöckmann F; Nustede R; Schlemminger R; Köhler H; Ramadori G; Peiper HJ
    Ann N Y Acad Sci; 1994 Mar; 713():427-8. PubMed ID: 8185209
    [No Abstract]   [Full Text] [Related]  

  • 38. [Interaction of vagal stimulation and duodenal acidification in the regulation of pancreatic secretion].
    Mei MH; Chen Q
    Sheng Li Xue Bao; 1985 Oct; 37(5):410-5. PubMed ID: 3837339
    [No Abstract]   [Full Text] [Related]  

  • 39. Physiological mechanisms of cholecystokinin action on pancreatic secretion.
    Owyang C
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G1-7. PubMed ID: 8760100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some aspects of vagal control of exocrine pancreatic secretion in rabbits (author's transl)].
    Vega MD; Esteller A; Varela G; Murillo A
    Rev Esp Fisiol; 1977 Sep; 33(3):211-5. PubMed ID: 897324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.